All your resource are belong to us
- Home
- Market Dynamics Info
- Resource Library
- Resources
- 2011 HIV/AIDS Diagnostic Technology Landscape Semi-Annual Update
- 2011 HIV/AIDS Diagnostic Technology Landscape: 2nd Edition
- 2011 Malaria Diagnostic Technology Landscape
- 2012 HIV/AIDS Diagnostic Technology Landscape Semi-annual Update
- 2012 HIV/AIDS Diagnostic Technology Landscape: 2nd Edition
- 2012 Malaria Diagnostics Market Landscape
- 2012 Malaria Diagnostics Technology Landscape Semi-annual Update
- 2012 Tuberculosis Diagnostic Technology Landscape
- 2012 Tuberculosis Diagnostic Technology Landscape Semi-annual Update
- 2012 Tuberculosis Medicines Technology Landscape
- 2013 HIV Preventives Technology and Market Landscape 1st Edition
- 2013 HIV/AIDS Diagnostic Technology Landscape 3rd Edition
- 2013 HIV/AIDS Diagnostic Technology Landscape Semi-annual Update
- 2013 Malaria Diagnostics Market Landscape Update
- 2013 Malaria Vector Control Commodities Landscape
- 2013 Pneumococcal AMC Annual Report
- 2013 Tuberculosis Diagnostics Technology and Market Landscape: 2nd Edition
- 2013 Tuberculosis Medicines Technology and Market Landscape: 1st Edition
- 2014 Tuberculosis Diagnostics Technology and Market Landscape: 3rd Edition
- 2014 Tuberculosis Medicines Technology and Market Landscape
- A forecasting guide for new and underused methods of family planning
- A Review of the AZD5847 Patent Landscape
- A Review of the Bedaquiline Patent Landscape
- A Review of the Delamanid Patent Landscape
- A Review of the PA-824 Patent Landscape
- A Review of the SQ-109 Patent Landscape
- A Review of the Sutezolid (PNU-100480) Patent Landscape
- Advance market commitment for pneumococcal vaccines: putting theory into practice
- Advance Market Commitments for Vaccines Against Neglected Diseases
- An Evaluation of Drug-Resistant TB Treatment Scale-up
- Beyond the Microscope
- CHAI ARV Market Report November 2013
- Demand Forecast for Artemisinin-based Combination Therapies (ACTs) in 2012-2013 Q1-2012 Report
- Demand Forecast for Artemisinin-based Combination Therapies (ACTs) in 2012-2013 Q2-2012 Report
- Demand Forecast for Artemisinin-based Combination Therapies (ACTs) in 2012-2013 Q3-2012 Report
- Designing a Global Financing and Procurement Mechanism for Reproductive Health Supplies
- Diagnostic market analysis: HIV simple/rapid, enzyme immunoassay (EIA) and supplemental tests
- DR-TB Drugs Fact Sheet
- DR-TB Drugs under the microscope: 1st Edition
- DR-TB Drugs under the microscope: 2nd edition
- DR-TB Drugs under the microscope: 3rd Edition
- Drugs and Vaccines for Developing Countries
- Expanding Access to LLINs
- Financing Medical Innovation Through Alternative Mechanisms
- Healthy Markets for Global Health
- Hepatitis C Medicines: Technology and Market Landscape
- HIV, Tuberculosis and Malaria Medicines Landscape
- Idea to Impact
- Jadelle Access Program
- Lessons learned in shaping vaccine markets in low-income countries
- Making Markets for Vaccines: Ideas to action
- Market Dynamics: Mechanisms and case studies fact pack
- Market Shaping for Family Planning
- Market Shaping for Family Planning Products
- Market Shaping Strategy: Voluntary Pooled Procurement
- Market shaping: access to low and sustainable vaccine prices
- Medicine prices in urban Mozambique
- Michael Porter on competition
- Nutrition for a Better Tomorrow
- Out of Step: Deadly implementation gaps in the TB response
- Overview of the HIV/AIDS antiretroviral medicines pipeline and existing products on the market
- Pharmaceutical Pricing in Emerging Markets
- Pneumococcal Advance Market Commitment
- Policy Brief: ACT Demand Forecast, 2012-2013
- Reduced price on rotavirus vaccines
- Regional group purchasing of vaccines
- Registering medicines for low-income countries
- Rethinking and reinventing Michael Porter’s five forces model
- Solutions to improve access to medicines and biomedical innovation through EU trade and R&D policy
- Split or Pool? Fundamental Trade-offs in Supplier Selection
- Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
- Striking the right balance – Accessing new anti-tuberculosis drugs in India
- The Advance Market Commitment for Pneumococcal Vaccines
- The Five Competitive Forces That Shape Strategy
- The Pledge Guarantee (PG) and Minimum Volume Guarantee (MVG)
- The Trans-Pacific Partnership Agreement
- The ‘3P Project’
- Tuberculosis Diagnosis and Drug Sensitivity Testing
- Vaccine Supply: A Cross-National Perspective
- Value for Money in LLIN Specifications Guidance
- Why UNITAID Matters for People Living with HIV/AIDS, TB and Malaria
- Send Proposed Resource
Global Health Market Dynamics 